X0306 4 2020-05-04 0 0000815094 ABIOMED INC ABMD 0001017832 SUTTER MARTIN P 22 CHERRY HILL DRIVE DANVERS MA 01923 1 0 0 0 Common Stock, $0.01 par value 2020-05-04 4 M 0 12000 9.99 A 200939 D Common Stock, $0.01 par value 2020-05-04 4 S 0 2290 178.4428 D 198649 D Common Stock, $0.01 par value 2020-05-04 4 S 0 1400 179.3450 D 197249 D Common Stock, $0.01 par value 2020-05-04 4 S 0 1100 180.3891 D 196149 D Common Stock, $0.01 par value 2020-05-04 4 S 0 6584 181.4645 D 189565 D Common Stock, $0.01 par value 2020-05-04 4 S 0 626 182.1418 D 188939 D Stock Option (right to buy) 9.99 2020-05-04 4 M 0 12000 0 D 2011-08-10 2020-08-11 Common Stock 12000 0 D Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan. Exercise of stock options in advance of the expiration of ten year contractual term of the underlying awards. Sale of common stock solely for the payment of tax liability associated with the exercise of options. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $177.9600 and $178.8900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $178.9600 and $179.7100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $180.0000 and $180.9050. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $180.9900 and $181.9300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $181.9900 and $182.1900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. /s/ Stephen C. McEvoy (by power of attorney) 2020-05-06